Cargando…
Advancement of chimeric antigen receptor-natural killer cells targeting hepatocellular carcinoma
With the advance of genome engineering technology, chimeric antigen receptors (CARs)-based immunotherapy has become an emerging therapeutic strategy for tumors. Although initially designed for T cells in tumor immunotherapy, CARs have been exploited to modify the function of natural killer (NK) cell...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713322/ https://www.ncbi.nlm.nih.gov/pubmed/35070039 http://dx.doi.org/10.4251/wjgo.v13.i12.2029 |